Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Edwards Lifesciences, a developer of hemodynamic monitoring systems, has launched the new third generation software for its minimally invasive FloTrac cardiac monitoring system that enhances the product's accuracy when used in patients with sepsis and other critical illnesses.
Subscribe to our email newsletter
According to Edwards Lifesciences, the new software draws upon analysis and a broader patient database to enable the FloTrac system to automatically and accurately adjust to the radical changes that occur in these patients.
The FloTrac system is a minimally invasive monitoring system that provides continuous cardiac measurements of patients in a critical care environment. This easy-to-use system accesses patient data directly from an existing arterial line, a small catheter inserted into the patient’s radial artery, the company said.
Carlyn Solomon, corporate vice president of critical care and vascular at Edwards Lifesciences, said: “Sepsis is the leading cause of death in the non-coronary intensive care unit and it is important to provide clinicians with an advanced tool that will help them treat this challenging patient population.”